Clinical guideline reveals reduced exacerbation risk with corticosteroid inhalers in asthma patients, highlighting a definitive departure from bronchodilator monotherapy.
GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.http://bit.ly/310LLzE
No takes yet. Share an insight, caveat, or question.
Reddel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: